| 000 | 01843 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250513202658.0 | ||
| 264 | 0 | _c20000229 | |
| 008 | 200002s 0 0 eng d | ||
| 022 | _a0002-953X | ||
| 024 | 7 |
_a10.1176/appi.ajp.157.2.269 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLaakso, A | |
| 245 | 0 | 0 |
_aStriatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography. _h[electronic resource] |
| 260 |
_bThe American journal of psychiatry _cFeb 2000 |
||
| 300 |
_a269-71 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBrain _xphysiopathology |
| 650 | 0 | 4 |
_aCarrier Proteins _xchemistry |
| 650 | 0 | 4 |
_aCaudate Nucleus _xchemistry |
| 650 | 0 | 4 |
_aCocaine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aCorpus Striatum _xchemistry |
| 650 | 0 | 4 |
_aDopamine _xchemistry |
| 650 | 0 | 4 | _aDopamine Plasma Membrane Transport Proteins |
| 650 | 0 | 4 | _aDopamine Uptake Inhibitors |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFunctional Laterality _xphysiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMembrane Glycoproteins |
| 650 | 0 | 4 | _aMembrane Transport Proteins |
| 650 | 0 | 4 | _aNerve Tissue Proteins |
| 650 | 0 | 4 |
_aSchizophrenia _xdiagnostic imaging |
| 650 | 0 | 4 | _aTomography, Emission-Computed |
| 700 | 1 | _aVilkman, H | |
| 700 | 1 | _aAlakare, B | |
| 700 | 1 | _aHaaparanta, M | |
| 700 | 1 | _aBergman, J | |
| 700 | 1 | _aSolin, O | |
| 700 | 1 | _aPeurasaari, J | |
| 700 | 1 | _aRäkköläinen, V | |
| 700 | 1 | _aSyvälahti, E | |
| 700 | 1 | _aHietala, J | |
| 773 | 0 |
_tThe American journal of psychiatry _gvol. 157 _gno. 2 _gp. 269-71 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1176/appi.ajp.157.2.269 _zAvailable from publisher's website |
| 999 |
_c10625837 _d10625837 |
||